ROIV ROIVANT SCIENCES LTD Product Launches 8-K Filing 2023 - Product Launch Roivant Sciences' subsidiary, Immunovant, Inc., announced initial data from a Phase 1 trial of IMVT-1402 in a press release and presentation.Get access to all SEC 8-K filings of the ROIVANT SCIENCES LTD